Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bentley reports positive results from phase II clinical study of Nasulin for type 2 diabetes

Feb. 14, 2008

Positive efficacy data reported from phase II Gabapentin GR trial

Feb. 13, 2008

Keryx Biopharmaceuticals completes phase III clinical trial of Sulonex

Feb. 13, 2008

Symbollon Pharmaceuticals completes phase III trial of IoGen for fibrocystic breast disease

Feb. 12, 2008

Merck KGaA and Novo Nordisk disclose new diabetes compounds in recent patent literature

Feb. 12, 2008

NHLBI changes intensive blood sugar treatment strategy in ACCORD trial

Feb. 8, 2008

Meditrina enters into exclusive global license agreement with AstraZeneca

Feb. 8, 2008

Romiplostim increases platelet counts in immune thrombocytopenic purpura

Feb. 8, 2008

Biovitrum and Symphogen complete phase I recombinant polyclonal antibody trial

Feb. 7, 2008

7TM Pharma selects new preclinical candidate for obesity and type 2 diabetes

Feb. 7, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...